Detalhe da pesquisa
1.
Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy.
Int Heart J
; 65(2): 211-217, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38556332
2.
Genetic Variations and Neuropathologic Features of Patients with PRKN Mutations.
Mov Disord
; 36(7): 1634-1643, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570211
3.
The Combined Efficacy of a Two-Year Period of Cybernic Treatment With a Wearable Cyborg Hybrid-Assistive Limb and Leuprorelin Therapy in a Patient With Spinal and Bulbar Muscular Atrophy: A Case Report.
Front Neurol
; 13: 905613, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35812096
4.
Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001).
Orphanet J Rare Dis
; 16(1): 304, 2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233722
5.
Becker muscular dystrophy caused by exon 2-truncating mutation of DMD.
Hum Genome Var
; 6: 52, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754439
6.
[A case of primary central nervous system malignant lymphoma developing from the optic chiasma and hypothalamus].
Rinsho Shinkeigaku
; 46(7): 475-9, 2006 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-17061700
7.
Effects of Alda-1, an Aldehyde Dehydrogenase-2 Agonist, on Hypoglycemic Neuronal Death.
PLoS One
; 10(6): e0128844, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26083658
8.
Predictors of outcome in hypoglycemic encephalopathy.
Diabetes Res Clin Pract
; 101(2): 159-63, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23820485